Hanpoong Pharmaceutical (CEO Jo In-sik, Cho Hyung-kwon) announced on the 11th that it held an overseas workshop for all sales departments for 5 days in Da Nang, Vietnam from July 5.
This workshop was held under the theme of communication and collaboration as well as strengthening organization and competitiveness in a rapidly changing pharmaceutical environment. In addition, we had time to check the sales target for the first half of 2023, encourage growth compared to the previous year, and strengthen our will to achieve the 2023 goal.
CEO Jo In-sik said, “We prepared a special event because there is 다낭 밤문화 no growth of the company without the happiness of our employees.”
On the other hand, Hanpoong Pharmaceutical is engaged in oriental medicine health insurance more info monomixtures, general medicines, health functional foods, oriental medicine raw materials, and CMO business. are produced and supplied to pharmacies.
Until recently, it invested 30 billion won to complete the construction of a new factory dedicated to general medicines CMO with an exclusive area of 2,500 pyeong, and is producing about 10 types of consigned products such as multivitamins and Kyungokgo. In addition, by acquiring BGMP, cooperating with other companies in the development of new drugs, and supplying herbal raw materials for natural herbal medicines is showing rapid growth.